Healthcare3 months ago
Suven Life Sciences Limited Announces Positive Topline Results from Phase-2b Clinical Proof-of-concept Trial of Ropanicant for Major Depressive Disorder
Suven Life Sciences Limited (SUVEN) shares positive topline results from Phase-2b trial of Ropanicant for Major Depressive Disorder.
